ES2037908T3 - Un procedimiento para la preparacion de una tableta de capas multiples en una forma de dosificacion unitaria solida. - Google Patents

Un procedimiento para la preparacion de una tableta de capas multiples en una forma de dosificacion unitaria solida.

Info

Publication number
ES2037908T3
ES2037908T3 ES198989109925T ES89109925T ES2037908T3 ES 2037908 T3 ES2037908 T3 ES 2037908T3 ES 198989109925 T ES198989109925 T ES 198989109925T ES 89109925 T ES89109925 T ES 89109925T ES 2037908 T3 ES2037908 T3 ES 2037908T3
Authority
ES
Spain
Prior art keywords
procedure
preparation
dosage form
unit dosage
multiple layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989109925T
Other languages
English (en)
Inventor
Herbert Schock
William R. Nadler
David F. Long
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2037908T3 publication Critical patent/ES2037908T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION ES DIRIGIDA A UNA TABLETA MULTILAMINADA QUE CONTIENE UNA LAMINA IBUPROFENO, UNA LAMINA ANTIHISTAMINICA PIPERIDINOALCANOL, Y UNA LAMINA O LAMINAS QUE CONTIENEN EXCIPIENTE FARMACEUTICOS CONVENCIONALES, LA CUAL ES ENTREMEZCLADA ENTRE EL IBUPROFEN Y LA LAMINA PIPERIDINOALCANOL Y SIRVE PARA SEPARARLOS FISICAMENTE. ESTA TABLETA SOLVENTA LOS PROBLEMAS ASOCIADOS CON LAS INCOMPATIBILIDADES FISICAS Y QUIMICAS ENTRE EL IBUPROFENO Y LOS ANTIHISTAMINICOS PIPERIDINOALCANOL.
ES198989109925T 1988-06-01 1989-06-01 Un procedimiento para la preparacion de una tableta de capas multiples en una forma de dosificacion unitaria solida. Expired - Lifetime ES2037908T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20081788A 1988-06-01 1988-06-01
US07/344,183 US4999226A (en) 1988-06-01 1989-04-27 Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination

Publications (1)

Publication Number Publication Date
ES2037908T3 true ES2037908T3 (es) 1993-07-01

Family

ID=26896133

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989109925T Expired - Lifetime ES2037908T3 (es) 1988-06-01 1989-06-01 Un procedimiento para la preparacion de una tableta de capas multiples en una forma de dosificacion unitaria solida.

Country Status (17)

Country Link
US (1) US4999226A (es)
EP (1) EP0348683B1 (es)
JP (1) JP2757017B2 (es)
KR (1) KR0126129B1 (es)
CN (1) CN1038021A (es)
AU (1) AU615751B2 (es)
CA (1) CA1327011C (es)
DE (1) DE68900378D1 (es)
DK (1) DK174638B1 (es)
ES (1) ES2037908T3 (es)
FI (1) FI90205C (es)
GR (1) GR3003477T3 (es)
HU (1) HU202746B (es)
IE (1) IE61182B1 (es)
IL (1) IL90461A0 (es)
NZ (1) NZ229325A (es)
PT (1) PT90689B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
JPH069382A (ja) * 1992-04-17 1994-01-18 Takeda Chem Ind Ltd 安定化された固型製剤およびその製造方法
JPH08506808A (ja) * 1992-12-21 1996-07-23 ザ、プロクター、エンド、ギャンブル、カンパニー 呼吸障害治療用組成物の製造における鎮痛剤ｓ（＋）対掌体の利用
CN1071570C (zh) * 1993-06-14 2001-09-26 詹森药业有限公司 阿司咪唑和假麻黄碱的缓释薄膜包衣片
KR100338877B1 (ko) * 1993-10-25 2002-12-05 메렐 파마슈티칼스 인크. 테르페나딘과이부프로펜의안정한약제학적조성물
KR100347631B1 (ko) * 1993-12-10 2002-11-29 후지사와 야꾸힝 고교 가부시키가이샤 해열진통배합제
US5419917A (en) * 1994-02-14 1995-05-30 Andrx Pharmaceuticals, Inc. Controlled release hydrogel formulation
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
EP0812195B1 (en) * 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol compounds
US5574045A (en) * 1995-06-06 1996-11-12 Hoechst Marion Roussel, Inc. Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
US6077539A (en) 1996-11-12 2000-06-20 Pozen, Inc. Treatment of migraine headache
NZ501248A (en) * 1997-08-26 2001-06-29 Aventis Pharma Inc Pharmaceutical composition for combination of piperidinoalkanol-decongestant
AR030920A1 (es) * 1999-11-16 2003-09-03 Smithkline Beecham Plc Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones
AU2002220248A1 (en) * 2000-11-06 2002-05-15 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US20040018239A1 (en) * 2000-11-17 2004-01-29 Hajime Ishida Pharmaceutical preparation containing copolyvidone
CA2447984A1 (en) * 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Dosage forms having an inner core and outer shell with different shapes
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20040253311A1 (en) * 2002-12-18 2004-12-16 Roger Berlin Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
US20050220877A1 (en) * 2004-03-31 2005-10-06 Patel Ashish A Bilayer tablet comprising an antihistamine and a decongestant
CA2565029C (en) * 2004-05-21 2013-09-03 Lawrence Solomon Immediate release pharmaceutical tablets with height greater than width
CN1964703B (zh) * 2004-05-21 2012-07-04 阿库-伯雷克技术公司 高度超过宽度的速释药片
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
EP1970055B1 (en) 2005-12-29 2010-11-24 Osmotica Kereskedelmi És Szolgáltató Kft Multi-layered tablet with triple release combination
CA2748783A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
CA2750196C (en) 2009-01-05 2017-06-20 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
CA2748728C (en) 2009-01-05 2017-01-03 Mcneil-Ppc, Inc. Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
US20130115250A1 (en) * 2009-05-13 2013-05-09 Wyeth Llc Burst Drug Release Compositions
EP3551173A1 (en) 2016-12-09 2019-10-16 Bayer Animal Health GmbH Pharmaceutical preparation and method for its manufacture
CN108703828B (zh) * 2018-06-04 2021-03-30 王荣涛 下肢牵引器
CN109481272B (zh) * 2019-01-10 2020-07-24 河南省洛阳正骨医院（河南省骨科医院） 肺癌骨转移术后康复装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70071A (en) * 1982-11-01 1987-12-31 Merrell Dow Pharma Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient
US4882167A (en) * 1983-05-31 1989-11-21 Jang Choong Gook Dry direct compression compositions for controlled release dosage forms
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4806359A (en) * 1987-04-22 1989-02-21 Mcneilab, Inc. Iburprofen sustained release matrix and process
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method

Also Published As

Publication number Publication date
US4999226A (en) 1991-03-12
FI90205B (fi) 1993-09-30
AU615751B2 (en) 1991-10-10
HUT52367A (en) 1990-07-28
KR900017573A (ko) 1990-12-19
IE891795L (en) 1989-12-01
IL90461A0 (en) 1990-01-18
NZ229325A (en) 1990-10-26
PT90689A (pt) 1989-12-29
DK265489A (da) 1989-12-02
IE61182B1 (en) 1994-10-05
DE68900378D1 (de) 1991-12-05
FI892640L (fi) 1989-12-02
EP0348683A1 (en) 1990-01-03
EP0348683B1 (en) 1991-10-30
JPH0228111A (ja) 1990-01-30
DK265489D0 (da) 1989-05-31
GR3003477T3 (en) 1993-02-17
CA1327011C (en) 1994-02-15
FI892640A0 (fi) 1989-05-31
PT90689B (pt) 1993-12-31
HU202746B (en) 1991-04-29
JP2757017B2 (ja) 1998-05-25
FI90205C (fi) 1994-01-10
AU3580089A (en) 1989-12-07
KR0126129B1 (ko) 1997-12-24
CN1038021A (zh) 1989-12-20
DK174638B1 (da) 2003-08-04

Similar Documents

Publication Publication Date Title
ES2008580A6 (es) Forma de dosificacion para la liberacion rapida y lenta de agente beneficioso.
ES2110633T3 (es) Composicion estable de dosificacion oral de liberacion prolongada.
ES2060825T3 (es) Un sistema terapeutico para el administracion retardada y controlada de sustancias activas por via percutanea o a traves de la mucosa.
MX9203557A (es) Una forma de dosis para suministrar el farmaco benefico verapamil.
AR002275A1 (es) Forma de dosificacion farmaceutica oral, procedimiento para la manufactura de una forma de dosificacion fija, y uso de dicha forma de dosificacionfarmaceutica oral.
ES2188126T3 (es) Unidad de envasado primario para formas de administracion en peliculas u obleas.
ES2064451T3 (es) Compresa sanitaria integral.
IT8719064A0 (it) Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive.
ES2181962T3 (es) Panel de soporte para asegurar miembros de formacion de pared externa.
ES2117146T3 (es) Tableta farmaceutica capaz de liberar una o varias sustancias medicamentosas a diferentes velocidades.
CO5251435A1 (es) Composicion orales estables de liberacion extendida que comprenden un nucleo de pseudoefedrina, una capa de separacion y una capa de desloratadina
BR0109575A (pt) Formulação terapêutica, forma de dosagem oral, processo para a preparação de pelo menos uma pequena conta, e, pequena conta
ES2107235T3 (es) Tableta de liberacion prolongada, revestida con pelicula, de astemizol y pseudoefedrina.
AR008002A1 (es) Formulaciones de unidades múltiples de tramadol y procedimiento para prepararlas.
AR026968A1 (es) Una tableta matriz que permite la liberacion prolongada de trimetazidina lluego de su administracion por via oral
GB1509979A (en) Pharmaceutical compositions containing aspirin or indomethacin
CO4770978A1 (es) Empleo de epinastina para el tratamiento de dolores
AR013052A1 (es) Una forma de dosis oral solida que comprende una combinacion de metformin y glibenclamida
ES2080307T3 (es) Composiciones farmaceuticas.
AR025052A1 (es) Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos.
MX169815B (es) Tableta de medicamento masticable que contiene medios para enmascarar el sabor
UY26371A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
CO5011082A1 (es) Formulacion medicamentosa con liberacion controlada de sus- tancia activa
ES2148470T3 (es) Farmaco analgesico antipiretico combinado.
ES2193233T3 (es) Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 348683

Country of ref document: ES